SEREVENT

Prescription medicines

SEREVENT

Product information:

SEREVENT product monograph

Health-care Professional Information:

September 7, 2005 - New safety information regarding SEREVENT

August 15, 2003 - Important safety information regarding SEREVENT (salmeterol xinafoate) inhalation aerosol

Patient information:

October 4, 2005 - safety information about a class of asthma drugs known as long-acting beta-2 agonists

September 4, 2003 - Important safety information regarding SEREVENT (salmeterol xinafoate) inhalation aerosol

 

Trademarks are owned by or licensed to the GSK group of companies.